MARKER THERAPEUTICS, INC. Gain (Loss) on Sale of Derivatives
MARKER THERAPEUTICS, INC. (MRKR) reported Gain (Loss) on Sale of Derivatives of $290.50 thousand for the 173-month period ending 2013-12-31, per its 10-Q/A filed 2014-05-21.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2014-05-21
- MARKER THERAPEUTICS, INC. gain (loss) on sale of derivatives for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. gain (loss) on sale of derivatives for the quarter ending 2011-12-31 was -$798.08K.
- MARKER THERAPEUTICS, INC. gain (loss) on sale of derivatives for the quarter ending 2011-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. gain (loss) on sale of derivatives for the quarter ending 2011-06-30 was $396.00K.
- MARKER THERAPEUTICS, INC. gain (loss) on sale of derivatives for fiscal 2011 was $290.50K.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month | Gain (Loss) on Sale of Derivatives 12 month | Gain (Loss) on Sale of Derivatives 143 month | Gain (Loss) on Sale of Derivatives 146 month | Gain (Loss) on Sale of Derivatives 149 month | Gain (Loss) on Sale of Derivatives 152 month | Gain (Loss) on Sale of Derivatives 155 month | Gain (Loss) on Sale of Derivatives 158 month | Gain (Loss) on Sale of Derivatives 161 month | Gain (Loss) on Sale of Derivatives 164 month | Gain (Loss) on Sale of Derivatives 167 month | Gain (Loss) on Sale of Derivatives 170 month | Gain (Loss) on Sale of Derivatives 173 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $290.50K 10-Q/A · filed 2014-05-21 | ||||||||||||||
| 2013-09-30 | $290.50K 10-Q · filed 2013-11-19 | ||||||||||||||
| 2013-06-30 | $290.50K 10-Q · filed 2013-08-19 | ||||||||||||||
| 2013-03-31 | $290.50K 10-Q/A · filed 2013-08-19 | ||||||||||||||
| 2012-12-31 | $290.50K 10-K · filed 2013-05-15 | ||||||||||||||
| 2012-09-30 | $290.50K 10-Q · filed 2012-11-19 | ||||||||||||||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $290.50K 10-Q/A · filed 2012-09-12 | ||||||||||||
| 2012-03-31 | $290.50K 10-Q · filed 2012-05-21 | ||||||||||||||
| 2011-12-31 | -$798.08K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | -$798.08K derived: sum of 2 quarters · filed 2013-05-15 | -$402.07K derived: sum of 3 quarters · filed 2013-05-15 | $290.50K 10-K · filed 2013-05-15 | $290.50K 10-K · filed 2012-04-16 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $396.00K derived: sum of 2 quarters · filed 2012-11-19 | $1.09M 10-Q · filed 2012-11-19 | $1.09M 10-Q · filed 2011-11-21 | |||||||||||
| 2011-06-30 | $396.00K 10-Q/A · filed 2012-09-12 | $1.09M 10-Q/A · filed 2012-09-12 | $1.09M 10-Q · filed 2011-08-22 | ||||||||||||
| 2011-03-31 | $290.50K 10-Q · filed 2012-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |